Fig. 2: Serosurvey scheme and vaccination profile of the surveyed population. | Nature Communications

Fig. 2: Serosurvey scheme and vaccination profile of the surveyed population.

From: Molecular epidemiology and population immunity of SARS-CoV-2 in Guangdong (2022–2023) following a pivotal shift in the pandemic

Fig. 2

a The scheme of serosurvey was conducted before and after each epidemic wave, with the corresponding timing marked by dashed vertical lines. The SARS-CoV-2 viral loads detected in Guangzhou’s sewage (marked by purple line) and nationally reported SARS-CoV-2 positive percentage in influenza-like illnesses (ILIs) (sourced from https://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_13141/202401/t20240110_271902.html, in Chinese) (marked by orange line) were plotted to show the epidemiological dynamics. b The cumulative percentage of 2nd and 3rd serosurvey population that had been vaccinated. A total of 1446 individuals with immunological backgrounds were included in the count. The vaccinated population is color-coded as follows: the first dose in orange, the second dose in green, the third dose in red, and the fourth dose in purple. c The overview of vaccination status among the surveyed subpopulations (n = 1408). Inactivated-virus vaccination (individuals received one to four doses of vaccination with the primary does being an inactivated-virus vaccine); unvaccinated (individuals who had not received any vaccination); others (those who had primarily received recombinant protein vaccine or adenovirus vaccine). A stacked column format on the right side of the panel showed the percentage of individuals with various vaccination statuses within each age group as of December 2023.

Back to article page